Clinical Trial Detail

NCT ID NCT02676323
Title Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Cytarabine + Fludarabine + Leucovorin + Panobinostat

Age Groups: child adult

No variant requirements are available.